BRYXTA 400MG INJECTION
Manufacturer- ZYDUS CADILAOrigin of Medicine : India.
Introduction- Bryxta 400mg Injection is an anticancer medicine consisting of the active ingredient Bevacizumab. It is indicated along with other chemotherapy drugs to treat metastatic breast cancer, brain cancer, cervical cancer, kidney cancer, lung cancer, and colorectal cancer. It is also used to treat cancers of the ovary, fallopian tube or primary peritoneal cancer. Use effective birth control during the treatment and for at least six months after the last dose. Bevacizumab Injection is not recommended for adolescents and children under the age of 18.
Constipation, appetite loss, runny nose, fever, skin problems, and weight loss are common side effects of Bryxta 400mg Injection. Before starting treatment with this medicine, let your doctor know if you have high blood pressure, high blood sugar, stomach disorders, heart problems, or have recently undergone surgery.